Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Cerebellar ataxia spatiotemporal transcriptomics atlas

Project description

Cerebellum atlas capturing the ‘signatures’ of cerebellar ataxia

Cerebellar ataxias are a family of rare, genetic neurodegenerative disorders characterised by loss of cerebellar Purkinje neurons. Although they are clinically homogeneous (loss of coordination and speech), they have high genetic heterogeneity (heterogeneous disease genes). Recent research has highlighted a commonality in dysregulation pathways, often involving calcium, glutamate and inositol phosphate signalling. However, the dysregulation mechanisms and their relation to Purkinje neurons are not known. With the support of the Marie Skłodowska-Curie Actions programme, the AtaxAtlas project aims to build a cerebellum atlas capturing the ‘signatures’ of cerebellar ataxia. To do so, it will leverage state-of-the-art single-cell approaches (transcriptomics and ‘protein validation’) in two cerebellar ataxia mouse models at two different disease stages.

Objective

Inherited Cerebellar ataxia (CAs) is a large and multifaceted group of rare genetic neurodegenerative diseases affecting mainly the cerebellum and its connection, leading to the loss of coordination and ataxia phenotype. Purkinje neurons (PN) are crucial cells for cerebellar functionality, but also very sensitive neurons. Indeed, they were found as the most vulnerable cerebellar neurons in many CAs, both in mouse and human samples. Although CAs show high genetic heterogeneity and have different disease-genes, they converge into similar phenotypic features and recent papers highlighted common deregulated key pathways. The current research landscape, indeed, points out towards the identification of calcium, glutamate and inositol phosphate signaling as frequently dysregulated. However, there is yet no comprehensive analysis of degenerative mechanisms, in particular in PNs, that could prioritize molecular targets for therapeutic development.
Our metanalysis readouts suggest converging pathophysiological points across different CAs, which so far remain poorly understood and need to be characterized. To this aim in this application, we propose to investigate in depth cerebellum CA signature taking advantage of cutting-edge single-cell profiling approaches in two flagship CA mouse models (SCA7, ARCA2) at two different disease stages. The combination of transcriptomics (single-nucleus RNA sequencing, probe-based spatial transcriptomics) and protein validation will help us to build a cerebellum atlas in the context of CA. The goal will be reached through the effort and synergism of a multi-disciplinary task force comprising biological, -omics approaches and computational expertise.
The results will be presented and communicated during international conferences, via social media and, finally, published in peer-reviewed journals in order to reach a broad scientific community. Also, the data will be used to inform lay audience through the collaboration with patient association

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2022-PF-01

See all projects funded under this call

Coordinator

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Net EU contribution
€ 195 914,88
Address
RUE DE TOLBIAC 101
75654 Paris
France
Region
Ile-de-France Ile-de-France Paris
Activity type
Research Organisations
Links
Total cost
No data

Partners (1)